Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.
Iijima Y, Sakakibara R, Ishizuka M, Honda T, Shirai T, Okamoto T, Tateishi T, Sakashita H, Tamaoka M, Takemoto A, Kumaki Y, Ikeda S, Miyazaki Y.
Iijima Y, et al. Among authors: ishizuka m.
Immunotherapy. 2020 Jun;12(8):563-569. doi: 10.2217/imt-2019-0142. Epub 2020 May 3.
Immunotherapy. 2020.
PMID: 32363992